Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients
Authors:
- 21 July 2006
- journal article
- Published by Springer Nature in European Spine Journal
- Vol. 15 (12) , 1777-1783
Abstract
Percutaneous vertebroplasty (PVP) is an efficient procedure to treat pain due to osteoporotic vertebral compression fractures (OVCFs). However, some patient populations experience recurrent vertebral fracture after initial successful procedure. There are a lot of literatures about the effectiveness of this procedure but few concerning the development of recurrent, new compression fracture. This is a retrospective review of all PVPs performed in author’s institution from September 1999 to December 2001 to investigate the factors related to the development of new symptomatic OVCFs after PVPs. A retrospective review of 244 cases of PVP for symptomatic OVCFs at 382 levels was performed. Sociodemographic, clinical, radiologic, and procedural data were analyzed and compared between the two patient groups (control group : no further symptomatic OVCFs after the initial PVP, “new symptomatic fracture” group: with newly developed symptomatic OVCF). Statistical analysis was performed between the variables of the two groups. Survival analysis was performed using the Kaplan–Meier method. Over all, 38 among 244 treated patients (15.6%) had experienced newly developed symptomatic OVCF(s) during the follow up period (mean 52.5 months). Old age and the presence of multiple treated vertebrae at the initial PVP were assessed as a strong parameter for predicting new symptomatic OVCF. With increasing preoperative wedging deformity the risk of developing new symptomatic OVCF decreased. The Kaplan-Meier estimate of the 1 year fracture-free rate was 92.2%. The Kaplan–Meier curve showed that 7.8% of the patients would experience new symptomatic OVCF within 1 year after initial PVP. A preoperative only mild wedge deformity of the fractured vertebra(e) could indicate the increased risk of developing new symptomatic OVCF after vertebroplasty.Keywords
This publication has 30 references indexed in Scilit:
- Calcium phosphate cement leakage after percutaneous vertebroplasty for osteoporotic vertebral fractures: risk factor analysis for cement leakageJournal of Neurosurgery: Spine, 2005
- Long-term pain relief effects in four patients undergoing percutaneous vertebroplasty for metastatic vertebral tumorJournal of Anesthesia, 2004
- Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplastyClinical Rheumatology, 2004
- Treatment of pain from osteoporotic vertebral collapse by percutaneous PMMA vertebroplastyActa Neurochirurgica, 2004
- Percutaneous vertebral augmentationThe Spine Journal, 2004
- Vertebroplasty in focal Paget disease of the spineJournal of Neurosurgery: Spine, 2003
- Preoperative and postoperative cognitive functioning in patients with frontal meningiomasJournal of Neurosurgery, 2003
- Changing patterns of insulin-like growth factor—I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegalyJournal of Neurosurgery, 2002
- Bone substitutes in vertebroplastyEuropean Spine Journal, 2001
- Vertebroplasty: techniques to avoid complicationsThe Spine Journal, 2001